Cite
MLA Citation
Kayvon Modjarrad et al.. “Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.” Lancet infectious diseases, vol. 19, no. 9, 2019, pp. 1013–1022. http://access.bl.uk/ark:/81055/vdc_100091276198.0x000034